Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
92.77%
Operating Margin
0.00%
Net Margin
-25.32%

Efficiency Metrics

Revenue per Expense Ratio
154,927,000.0
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
-0.8800000000

Balance Sheet Analysis

Current Ratio
0.09
Cash Ratio
0.09
Working Capital
$-3.37B
Debt to Equity
7.89
Debt to Assets
86.89%
Equity Ratio
11.02%

Cash Flow Analysis

Operating Cash Flow Ratio
5.17%
Free Cash Flow Ratio
5.17%
CapEx to Revenue
0.00%
Dividends Paid
$80.75M
Stock Buybacks
$9.76M
Total Shareholder Returns
$90.51M
Cash Position Change
-15.57%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
165.17%
Net Income
84.82%
EPS
87.25%
Operating Income
100.00%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
15.24%
Operating Cash Flow
-97.23%
Free Cash Flow
-97.23%

Balance Sheet Health

Assets
10.33%
Debt
9.69%
Book Value per Share
-10.13%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
-27.52%
Shares Outstanding
19.18%

Long Term Trends

3Y Revenue/Share
268.08%
5Y Revenue/Share
211.72%
3Y Dividend/Share
-54.68%
5Y Dividend/Share
-68.17%